检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring.

Martin Wasserbauer,Stepan Hlava,Jiri Drabek,Jan Stovicek,Petra Minarikova, Lenka Nedbalova,Tomas Drasar,Zdena Zadorova,Jiri Dolina,Stefan Konecny,Vladimír Kojecky,Jana Kozeluhova, Pavlina Cernikova,Dita Pichlerova,Barbora Kucerova,Stepan Coufal,Radan Keil

PloS one（2022）

引用 4|浏览12
暂无评分
摘要
This prospective observational study proved the effectiveness of the adalimumab biosimilars FKB327 and GP2017 in IBD.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要